221 related articles for article (PubMed ID: 36916882)
1. A lncRNA identifies
Xu H; Li Z; Kuo CC; Götz K; Look T; de Toledo MAS; Seré K; Costa IG; Zenke M
Elife; 2023 Mar; 12():. PubMed ID: 36916882
[TBL] [Abstract][Full Text] [Related]
2. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
[TBL] [Abstract][Full Text] [Related]
3.
Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
[TBL] [Abstract][Full Text] [Related]
4. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.
Sontag S; Förster M; Qin J; Wanek P; Mitzka S; Schüler HM; Koschmieder S; Rose-John S; Seré K; Zenke M
Stem Cells; 2017 Apr; 35(4):898-908. PubMed ID: 28090699
[TBL] [Abstract][Full Text] [Related]
5. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
Front Immunol; 2019; 10():173. PubMed ID: 30800127
[TBL] [Abstract][Full Text] [Related]
6. IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
Sichien D; Scott CL; Martens L; Vanderkerken M; Van Gassen S; Plantinga M; Joeris T; De Prijck S; Vanhoutte L; Vanheerswynghels M; Van Isterdael G; Toussaint W; Madeira FB; Vergote K; Agace WW; Clausen BE; Hammad H; Dalod M; Saeys Y; Lambrecht BN; Guilliams M
Immunity; 2016 Sep; 45(3):626-640. PubMed ID: 27637148
[TBL] [Abstract][Full Text] [Related]
7. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
[TBL] [Abstract][Full Text] [Related]
8. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
[TBL] [Abstract][Full Text] [Related]
9. Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans.
Cytlak U; Resteu A; Pagan S; Green K; Milne P; Maisuria S; McDonald D; Hulme G; Filby A; Carpenter B; Queen R; Hambleton S; Hague R; Lango Allen H; Thaventhiran JED; Doody G; Collin M; Bigley V
Immunity; 2020 Aug; 53(2):353-370.e8. PubMed ID: 32735845
[TBL] [Abstract][Full Text] [Related]
10. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
[TBL] [Abstract][Full Text] [Related]
11. A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.
Murakami K; Sasaki H; Nishiyama A; Kurotaki D; Kawase W; Ban T; Nakabayashi J; Kanzaki S; Sekita Y; Nakajima H; Ozato K; Kimura T; Tamura T
Nat Immunol; 2021 Mar; 22(3):301-311. PubMed ID: 33603226
[TBL] [Abstract][Full Text] [Related]
12. A negative feedback loop of transcription factors specifies alternative dendritic cell chromatin States.
Bornstein C; Winter D; Barnett-Itzhaki Z; David E; Kadri S; Garber M; Amit I
Mol Cell; 2014 Dec; 56(6):749-62. PubMed ID: 25453760
[TBL] [Abstract][Full Text] [Related]
13. Mutation in
Das A; Chauhan KS; Kumar H; Tailor P
Front Immunol; 2021; 12():758190. PubMed ID: 34867997
[TBL] [Abstract][Full Text] [Related]
14. Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8.
Anderson DA; Ou F; Kim S; Murphy TL; Murphy KM
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34958351
[TBL] [Abstract][Full Text] [Related]
15. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
[TBL] [Abstract][Full Text] [Related]
16. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.
Kurotaki D; Kawase W; Sasaki H; Nakabayashi J; Nishiyama A; Morse HC; Ozato K; Suzuki Y; Tamura T
Blood; 2019 Apr; 133(17):1803-1813. PubMed ID: 30796024
[TBL] [Abstract][Full Text] [Related]
18. Transcription Factor IRF8 Governs Enhancer Landscape Dynamics in Mononuclear Phagocyte Progenitors.
Kurotaki D; Nakabayashi J; Nishiyama A; Sasaki H; Kawase W; Kaneko N; Ochiai K; Igarashi K; Ozato K; Suzuki Y; Tamura T
Cell Rep; 2018 Mar; 22(10):2628-2641. PubMed ID: 29514092
[TBL] [Abstract][Full Text] [Related]
19. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development.
Jaiswal H; Kaushik M; Sougrat R; Gupta M; Dey A; Verma R; Ozato K; Tailor P
J Immunol; 2013 Dec; 191(12):5993-6001. PubMed ID: 24227775
[TBL] [Abstract][Full Text] [Related]
20. Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery.
Zhou T; Zhu X; Ye Z; Wang YF; Yao C; Xu N; Zhou M; Ma J; Qin Y; Shen Y; Tang Y; Yin Z; Xu H; Zhang Y; Zang X; Ding H; Yang W; Guo Y; Harley JB; Namjou B; Kaufman KM; Kottyan LC; Weirauch MT; Hou G; Shen N
Nat Commun; 2022 Apr; 13(1):1855. PubMed ID: 35388006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
